Cargando…

Role of PPARs in Trypanosoma cruzi Infection: Implications for Chagas Disease Therapy

Chagas disease, which is caused by Trypanosoma cruzi (T. cruzi), remains a substantial public health concern and an important cause of morbidity and mortality in Latin America. T. cruzi infection causes an intense inflammatory response in diverse tissues by triggering local expression of inflammator...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hovsepian, Eugenia, Penas, Federico, Mirkin, Gerardo A., Goren, Nora B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289900/ https://www.ncbi.nlm.nih.gov/pubmed/22448167 http://dx.doi.org/10.1155/2012/528435

Ejemplares similares

IL-10 Inhibits the NF-κB and ERK/MAPK-Mediated Production of Pro-Inflammatory Mediators by Up-Regulation of SOCS-3 in Trypanosoma cruzi-Infected Cardiomyocytes
por: Hovsepian, Eugenia, et al.
Publicado: (2013)

Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain
por: Cevey, Ágata Carolina, et al.
Publicado: (2015)

Aspirin Treatment of Mice Infected with Trypanosoma cruzi and Implications for the Pathogenesis of Chagas Disease
por: Mukherjee, Shankar, et al.
Publicado: (2011)

Treatment with Fenofibrate plus a low dose of Benznidazole attenuates cardiac dysfunction in experimental Chagas disease
por: Cevey, Ágata C., et al.
Publicado: (2017)

Evaluation of the Chagas VirClia(®) and Chagas TESA VirClia(®) for the Diagnosis of Trypanosoma cruzi Infection
por: García-Bermejo, Isabel, et al.
Publicado: (2022)

Meiotic sex in Chagas disease parasite Trypanosoma cruzi
por: Schwabl, Philipp, et al.
Publicado: (2019)

Peeking into the mysterious world of Trypanosoma cruzi and Chagas disease
por: Macedo, Andréa M, et al.
Publicado: (2022)

Trypanosoma cruzi and Chagas disease: diversity, progress and challenges
por: Miles, Michael A
Publicado: (2022)

Experimental Trypanosoma cruzi Infection and Chagas Disease—A Word of Caution
por: Talvani, André, et al.
Publicado: (2023)

Pyridinecarboxylic Acid Derivative Stimulates Pro-Angiogenic Mediators by PI3K/AKT/mTOR and Inhibits Reactive Nitrogen and Oxygen Species and NF-κB Activation Through a PPARγ-Dependent Pathway in T. cruzi-Infected Macrophages
por: Penas, Federico Nicolás, et al.
Publicado: (2020)

Treatment with a New Peroxisome Proliferator-Activated Receptor Gamma Agonist, Pyridinecarboxylic Acid Derivative, Increases Angiogenesis and Reduces Inflammatory Mediators in the Heart of Trypanosoma cruzi-Infected Mice
por: Penas, Federico Nicolás, et al.
Publicado: (2017)

Fenofibrate Increases the Population of Non-Classical Monocytes in Asymptomatic Chagas Disease Patients and Modulates Inflammatory Cytokines in PBMC
por: Pieralisi, Azul V., et al.
Publicado: (2022)

Trypanosoma cruzi loop-mediated isothermal amplification (Trypanosoma cruzi Loopamp) kit for detection of congenital, acute and Chagas disease reactivation
por: Besuschio, Susana A., et al.
Publicado: (2020)

Trypanocide Treatment of Women Infected with Trypanosoma cruzi and Its Effect on Preventing Congenital Chagas
por: Fabbro, Diana L., et al.
Publicado: (2014)

Is Antibody-Dependent Enhancement of Trypanosoma cruzi Infection Contributing to Congenital/Neonatal Chagas Disease?
por: Carlier, Yves, et al.
Publicado: (2021)

Revisiting Chagas' disease diagnostic strategies in light of different scenarios of Trypanosoma cruzi infection
por: Britto, Constança Carvalho
Publicado: (2022)

Strain-specific genome evolution in Trypanosoma cruzi, the agent of Chagas disease
por: Wang, Wei, et al.
Publicado: (2021)

Trypanosoma cruzi genetic diversity: impact on transmission cycles and Chagas disease
por: Zingales, Bianca, et al.
Publicado: (2022)

IL-10-Dependent and -Independent Mechanisms Are Involved in the Cardiac Pathology Modulation Mediated by Fenofibrate in an Experimental Model of Chagas Heart Disease
por: Rada, Jimena, et al.
Publicado: (2020)

Implication of Apoptosis for the Pathogenesis of Trypanosoma cruzi Infection
por: Decote-Ricardo, Débora, et al.
Publicado: (2017)

Mitochondrial dysfunction in Trypanosoma cruzi: the role of Serratia marcescens prodigiosin in the alternative treatment of Chagas disease
por: Genes, Carlos, et al.
Publicado: (2011)

Trypanosoma cruzi infection associated with atypical clinical manifestation during the acute phase of the Chagas disease
por: Rangel-Gamboa, Lucia, et al.
Publicado: (2019)

Chagas Immunochromatographic Rapid Test in the Serological Diagnosis of Trypanosoma cruzi Infection in Wild and Domestic Canids
por: Rodrigues, Esthefany S., et al.
Publicado: (2022)

Trypanosoma cruzi in the Chicken Model: Chagas-Like Heart Disease in the Absence of Parasitism
por: Teixeira, Antonio R. L., et al.
Publicado: (2011)

Chagas Cardiomyopathy Manifestations and Trypanosoma cruzi Genotypes Circulating in Chronic Chagasic Patients
por: Ramírez, Juan David, et al.
Publicado: (2010)

Métodos Diagnósticos para Trypanosoma cruzi en la enfermedad de Chagas : /
por: López Jiménez, Carlos Felipe
Publicado: (2015)

Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity
por: Zingales, Bianca, et al.
Publicado: (2014)

Detection of Trypanosoma cruzi by PCR in adults with chronic Chagas disease treated with nifurtimox
por: Vergara, Camilo, et al.
Publicado: (2019)

Fatal acute Chagas disease by Trypanosoma cruzi DTU TcI, Ecuador
por: Calvopina, Manuel, et al.
Publicado: (2020)

Nationwide Exposure of U.S. Working Dogs to the Chagas Disease Parasite, Trypanosoma cruzi
por: Meyers, Alyssa C., et al.
Publicado: (2020)

Trypanosoma cruzi parasitemia in chronic Chagas disease: Insights from hierarchical modeling
por: Abad-Franch, Fernando
Publicado: (2022)

Validation of the NAT Chagas IVD Kit for the Detection and Quantification of Trypanosoma cruzi in Blood Samples of Patients with Chagas Disease
por: Moreira, Otacilio C., et al.
Publicado: (2023)

Comparison of seven diagnostic tests to detect Trypanosoma cruzi infection in patients in chronic phase of Chagas disease
por: Duarte, Luisa Fernanda, et al.
Publicado: (2014)

Unraveling Chagas disease transmission through the oral route: Gateways to Trypanosoma cruzi infection and target tissues
por: Silva-dos-Santos, Danielle, et al.
Publicado: (2017)

Galectins in Chagas Disease: A Missing Link Between Trypanosoma cruzi Infection, Inflammation, and Tissue Damage
por: Poncini, Carolina V., et al.
Publicado: (2022)

Human Trypanosoma cruzi chronic infection leads to individual level steady-state parasitemia: Implications for drug-trial optimization in Chagas disease
por: De Salazar, Pablo M., et al.
Publicado: (2022)

Interactive Multimedia to Teach the Life Cycle of Trypanosoma cruzi, the Causative Agent of Chagas Disease
por: Teixeira, Dirceu E., et al.
Publicado: (2012)

Trypanosoma cruzi (Chagas' disease agent) reduces HIV-1 replication in human placenta
por: Dolcini, Guillermina Laura, et al.
Publicado: (2008)

Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease
Publicado: (1995)

The Potential Economic Value of a Trypanosoma cruzi (Chagas Disease) Vaccine in Latin America
por: Lee, Bruce Y., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_klko4dh5l4scjo6u68n9140ng3